AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32839200 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil + probiotics combination
Number of subjects: 270
Study 32839200 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 270
Study 36173066 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 20-80 mg/d
Number of subjects: 0
Study 36173066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32222960 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 54
Study 32222960 — intervention group
Group type: COMPARATOR
Intervention: Intercostal nerve block (ICNB)
Number of subjects: 54
Study 33458816 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice training for low-ability group
Number of subjects: 140
Study 33458816 — intervention group
Group type: COMPARATOR
Intervention: Discovery learning for low-ability group
Number of subjects: 140
Study 33458816 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice training for high-ability group
Number of subjects: 140
Study 33458816 — intervention group
Group type: COMPARATOR
Intervention: Discovery learning for high-ability group
Number of subjects: 140
Study 33458816 — intervention group
Group type: COMPARATOR
Intervention: Low-ability control group
Number of subjects: 140
Study 33458816 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-ability intervention group
Number of subjects: 140
Study 33458816 — intervention group
Group type: EXPERIMENTAL
Intervention: High-ability control group
Number of subjects: 140
Study 33458816 — intervention group
Group type: EXPERIMENTAL
Intervention: High-ability intervention group
Number of subjects: 140
Study 32941372 — intervention group
Group type: EXPERIMENTAL
Intervention: Running injury prevention intervention (details not specified)
Number of subjects: 138
Study 33481115 — intervention group
Group type: EXPERIMENTAL
Intervention: Music interventions (prerecorded music and live music)
Number of subjects: 467
Study 33481115 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 467
Study 35643872 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched seafood sticks (50 g/day containing 1010 CFUs of heat-inactivated B. animalis subsp. lactis CECT8145, 370 mg/day omega 3, and 1.7 g/day inulin)
Number of subjects: 120
Study 35643872 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched seafood sticks (50 g/day)
Number of subjects: 120
Study 35643872 — intervention group
Group type: COMPARATOR
Intervention: Placebo seafood sticks (50 g/day)
Number of subjects: 120
Study 34960058 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Glucose Eating Pattern (LGEP)
Number of subjects: 0
Study 35357457 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored message intervention
Number of subjects: 600
Study 35357457 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic message intervention
Number of subjects: 600
Study 35357457 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study 32933355 — intervention group
Group type: EXPERIMENTAL
Intervention: Response to treatment (exact intervention details not specified)
Number of subjects: 0
Study 32933355 — intervention group
Group type: COMPARATOR
Intervention: Disease progression
Number of subjects: 0
Study 35115346 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP devices turned on in operating rooms (ORs)
Number of subjects: 45000
Study 35115346 — intervention group
Group type: COMPARATOR
Intervention: PAP devices turned off in operating rooms (ORs)
Number of subjects: 45000
Study 33139853 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea consumption of ≥5 cups/week
Number of subjects: 4302
Study 33139853 — intervention group
Group type: COMPARATOR
Intervention: Green tea consumption of <1 cup/week
Number of subjects: 4302
Study 33139853 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmed cases using a diagnostic kit
Number of subjects: 4302
Study 35417756 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric Vacuum Aspiration (EVA)
Number of subjects: 146
Study 35417756 — intervention group
Group type: COMPARATOR
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 146
Study 34418082 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing with Roche Cobas
Number of subjects: 300
Study 34418082 — intervention group
Group type: COMPARATOR
Intervention: Cytology testing
Number of subjects: 300
Study 34677081 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit and Facebook-based physical activity intervention
Number of subjects: 50
Study 34677081 — intervention group
Group type: COMPARATOR
Intervention: Fitbit only (control)
Number of subjects: 50
Study 33317615 — intervention group
Group type: EXPERIMENTAL
Intervention: Web application (Naranj) for stress management
Number of subjects: 100
Study 33317615 — intervention group
Group type: COMPARATOR
Intervention: App unrelated to stress management (Control)
Number of subjects: 100
Study 34986013 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious Games (SGs) played for 1 week during clinical practice
Number of subjects: 60
Study 34986013 — intervention group
Group type: COMPARATOR
Intervention: Control group (no serious games)
Number of subjects: 60
Study 33755884 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 6 mg BID
Number of subjects: 0
Study 33755884 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 6 mg BID or higher
Number of subjects: 0
Study 33755884 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib (all dosages)
Number of subjects: 0
Study 33755884 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 6 mg BID and 24 mg BID
Number of subjects: 0
Study 33755884 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib 12 mg BID
Number of subjects: 0
Study 33755884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32171316 — intervention group
Group type: EXPERIMENTAL
Intervention: PAT‐A© intervention (individualised psychological treatment for anxiety)
Number of subjects: 40
Study 32171316 — intervention group
Group type: COMPARATOR
Intervention: Current Clinical Services Plus two emotional literacy skills sessions (control)
Number of subjects: 40
Study 36037303 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin in combination with chemoradiation (chemoRT)
Number of subjects: 10
Study 36037303 — intervention group
Group type: COMPARATOR
Intervention: Control (chemoRT alone)
Number of subjects: 10
Study 34581678 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention infographic about the scientific process
Number of subjects: 1017
Study 34581678 — intervention group
Group type: COMPARATOR
Intervention: Control infographic
Number of subjects: 1017
Study 36271332 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care Needs Assessment (PCNA) arm
Number of subjects: 320
Study 36271332 — intervention group
Group type: COMPARATOR
Intervention: Care-as-Usual arm
Number of subjects: 320
Study 32759096 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene membrane valve (PTFEV)
Number of subjects: 30
Study 32759096 — intervention group
Group type: COMPARATOR
Intervention: Transannular pericardial patch (TAP)
Number of subjects: 30
Study 35672074 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuroBall plus usual care
Number of subjects: 24
Study 35672074 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 24
Study 32473596 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic agents (especially heparin-based regimens)
Number of subjects: 0
Study 32473596 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulators with antithrombotic properties
Number of subjects: 0
Study 33480123 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmural Trauma Care Model (TTCM) implemented by a multidisciplinary team including trauma surgeon and hospital-based physical therapist, and a network of primary care trauma physical therapists
Number of subjects: 644
Study 33480123 — intervention group
Group type: COMPARATOR
Intervention: Usual care provided in participating hospitals
Number of subjects: 644
Study 35797775 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathways Early Autism Intervention
Number of subjects: 56
Study 34195468 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g soluble corn fiber (SCF)
Number of subjects: 243
Study 34195468 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg calcium
Number of subjects: 243
Study 34195468 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g SCF plus 600 mg calcium
Number of subjects: 243
Study 34195468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 34195468 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 243
Study 34556552 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component self-management intervention (data-logging nebulisers, digital platform, behavioural change sessions)
Number of subjects: 607
Study 34556552 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component self-management intervention
Number of subjects: 607
Study 34556552 — intervention group
Group type: COMPARATOR
Intervention: Usual care (data-logging nebulisers)
Number of subjects: 607
Study 34556552 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 607
Study 35134993 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief self-exercise education (brief-See)
Number of subjects: 46
Study 35134993 — intervention group
Group type: COMPARATOR
Intervention: Material-based education alone
Number of subjects: 46
Study 33583866 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular medical health check-ups for full-time employees
Number of subjects: 4652
Study 33583866 — intervention group
Group type: COMPARATOR
Intervention: Regular medical health check-ups for part-time employees
Number of subjects: 4652
Study 33583866 — intervention group
Group type: COMPARATOR
Intervention: Cost bearing for medical check-ups
Number of subjects: 4652
Study 33583866 — intervention group
Group type: COMPARATOR
Intervention: Workplace size impact on medical check-ups for part-timers
Number of subjects: 4652
Study 36461864 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous learning using ETMCPR through Zoom
Number of subjects: 61
Study 36461864 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous learning using ETMCPR module on e-learning platform
Number of subjects: 61
Study 36461864 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous learning
Number of subjects: 61
Study 33262113 — intervention group
Group type: EXPERIMENTAL
Intervention: Connected pre-habilitation program during neoadjuvant chemotherapy
Number of subjects: 136
Study 33262113 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 136
Study 35495881 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical theory of Traditional Chinese Medicine (TCM)
Number of subjects: 100
Study 35495881 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 100
Study 35495881 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical theory of TCM
Number of subjects: 100
Study 35390756 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase sleep condition (1.5 h/night increase)
Number of subjects: 37
Study 35390756 — intervention group
Group type: COMPARATOR
Intervention: Decrease sleep condition (1.5 h/night decrease)
Number of subjects: 37
Study 34578993 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgenic Camelina sativa oil (tCSO)
Number of subjects: 31
Study 34578993 — intervention group
Group type: COMPARATOR
Intervention: Fish oil (FO)
Number of subjects: 31
Study 35551646 — intervention group
Group type: EXPERIMENTAL
Intervention: IOT-based management of NIPPV
Number of subjects: 200
Study 35551646 — intervention group
Group type: COMPARATOR
Intervention: Usual NIPPV (control group)
Number of subjects: 200
Study 33227569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine treatment
Number of subjects: 54
Study 33227569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 32928732 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin monotherapy
Number of subjects: 9
Study 32928732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 35974039 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste recall training
Number of subjects: 42
Study 35974039 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study 34126996 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart Cherry (TC) 500 mg
Number of subjects: 13
Study 34126996 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 13
Study 35910406 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided intercostal nerve block with 0.25% ropivacaine and 5 mg dexamethasone
Number of subjects: 60
Study 35910406 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA) with fentanyl
Number of subjects: 60
Study 35236727 — intervention group
Group type: COMPARATOR
Intervention: Usual care waitlist control
Number of subjects: 281
Study 34593232 — intervention group
Group type: EXPERIMENTAL
Intervention: Tributyrin supplementation at 1 g/L
Number of subjects: 48
Study 34593232 — intervention group
Group type: EXPERIMENTAL
Intervention: Tributyrin supplementation at 2 g/L
Number of subjects: 48
Study 34593232 — intervention group
Group type: EXPERIMENTAL
Intervention: Tributyrin supplementation at 1 g/L and 2 g/L
Number of subjects: 48
Study 34593232 — intervention group
Group type: COMPARATOR
Intervention: Control (pasteurized waste milk without supplementation)
Number of subjects: 48
Study 35064588 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical mechanical debridement with photobiomodulation (test group)
Number of subjects: 34
Study 35064588 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical mechanical debridement without photobiomodulation (control group)
Number of subjects: 34
Study 35064588 — intervention group
Group type: COMPARATOR
Intervention: Comparison between test and control groups
Number of subjects: 34
Study 34943384 — intervention group
Group type: EXPERIMENTAL
Intervention: Uni-modal orofacial stimulation (OFS) over 10 consecutive days
Number of subjects: 35
Study 34943384 — intervention group
Group type: COMPARATOR
Intervention: Control group (no OFS)
Number of subjects: 35
Study 34943384 — intervention group
Group type: EXPERIMENTAL
Intervention: Uni-modal orofacial stimulation (OFS)
Number of subjects: 35
Study 32492185 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 1548
Study 35409732 — intervention group
Group type: EXPERIMENTAL
Intervention: HRBT-based PARIs intervention program
Number of subjects: 1044
Study 35409732 — intervention group
Group type: COMPARATOR
Intervention: Common health education program (control)
Number of subjects: 1044
Study 32475085 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-fat diet (20% energy from fat)
Number of subjects: 101
Study 32475085 — intervention group
Group type: COMPARATOR
Intervention: Moderate-fat diet (35% energy from fat)
Number of subjects: 101
Study 36167528 — intervention group
Group type: EXPERIMENTAL
Intervention: MERM device-observed self-administered therapy
Number of subjects: 114
Study 36167528 — intervention group
Group type: COMPARATOR
Intervention: Control (standard in-person directly observed therapy)
Number of subjects: 114
Study 33160091 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology and motivational interviewing (PP-MI) intervention
Number of subjects: 45
Study 33160091 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 45
Study 33160091 — intervention group
Group type: COMPARATOR
Intervention: Motivational interviewing alone (MI-alone)
Number of subjects: 45
Study 36240801 — intervention group
Group type: COMPARATOR
Intervention: 210 mg etrolizumab induction
Number of subjects: 385
Study 36240801 — intervention group
Group type: COMPARATOR
Intervention: 105 mg etrolizumab maintenance
Number of subjects: 385
Study 36240801 — intervention group
Group type: COMPARATOR
Intervention: 105 mg etrolizumab induction
Number of subjects: 385
Study 36240801 — intervention group
Group type: COMPARATOR
Intervention: Placebo induction
Number of subjects: 385
Study 36240801 — intervention group
Group type: COMPARATOR
Intervention: Etrolizumab maintenance
Number of subjects: 385
Study 36240801 — intervention group
Group type: COMPARATOR
Intervention: Placebo maintenance
Number of subjects: 385
Study 33637134 — intervention group
Group type: EXPERIMENTAL
Intervention: semi-standardized acupuncture plus routine care
Number of subjects: 110
Study 33637134 — intervention group
Group type: COMPARATOR
Intervention: routine care alone
Number of subjects: 110
Study 36514747 — intervention group
Group type: EXPERIMENTAL
Intervention: synbiotic + lactic acid bread (n=25)
Number of subjects: 100
Study 36514747 — intervention group
Group type: EXPERIMENTAL
Intervention: lactic acid bread (n=25)
Number of subjects: 100
Study 36514747 — intervention group
Group type: COMPARATOR
Intervention: control bread (n=25)
Number of subjects: 100
Study 34115399 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + ACT
Number of subjects: 35
Study 34717532 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg kg‐ 1)
Number of subjects: 106
Study 34717532 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (1.5 mg kg‐ 1) with additional propofol (0.5 mg kg‐ 1)
Number of subjects: 106
Study 33646594 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalomedial-to-lateral approach proctectomy (CEMP)
Number of subjects: 506
Study 33646594 — intervention group
Group type: COMPARATOR
Intervention: Medial-to-lateral approach proctectomy (MAP)
Number of subjects: 506
Study 33646594 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 506
Study 32174775 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol/remifentanil
Number of subjects: 128
Study 32174775 — intervention group
Group type: COMPARATOR
Intervention: Volatile anesthetics (VA) with sevoflurane or desflurane/remifentanil
Number of subjects: 128
Study 34281311 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated growth factors (CGF) associated with implants
Number of subjects: 52
Study 34281311 — intervention group
Group type: COMPARATOR
Intervention: Standard implant treatment (Control)
Number of subjects: 52
Study 32871702 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 32871702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35235632 — intervention group
Group type: EXPERIMENTAL
Intervention: Taper thread on straight-body implants with microthreads (group A)
Number of subjects: 142
Study 35235632 — intervention group
Group type: COMPARATOR
Intervention: Taper thread on straight-body implants without microthreads (group B)
Number of subjects: 142
Study 35235632 — intervention group
Group type: EXPERIMENTAL
Intervention: Implants inserted with IT > 50 Ncm
Number of subjects: 142
Study 32092617 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane blocks (ESPB)
Number of subjects: 66
Study 32092617 — intervention group
Group type: COMPARATOR
Intervention: Paravertebral block (PVB)
Number of subjects: 66
Study 36799922 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency cervical cerclage at 24–28 weeks gestation in addition to progesterone
Number of subjects: 0
Study 36799922 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34114717 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro health insurance (MHI) offered through informal financial institutions (Self-Help Groups)
Number of subjects: 0
Study 34128954 — intervention group
Group type: EXPERIMENTAL
Intervention: Pythagorean Self-Awareness Intervention (PSAI)
Number of subjects: 44
Study 34128954 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 33478173 — intervention group
Group type: EXPERIMENTAL
Intervention: African Circle Dance (ACD) intervention and psychoeducation
Number of subjects: 198
Study 33478173 — intervention group
Group type: COMPARATOR
Intervention: Control group (psychoeducation only)
Number of subjects: 198
Study 32044851 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (2 specific cases)
Number of subjects: 69
Study 32044851 — intervention group
Group type: COMPARATOR
Intervention: Group B (2 specific cases)
Number of subjects: 69
Study 32044851 — intervention group
Group type: EXPERIMENTAL
Intervention: Group AB (4 specific cases)
Number of subjects: 69
Study 36107233 — intervention group
Group type: EXPERIMENTAL
Intervention: CON-ECC
Number of subjects: 42
Study 36107233 — intervention group
Group type: EXPERIMENTAL
Intervention: ECC
Number of subjects: 42
Study 36107233 — intervention group
Group type: EXPERIMENTAL
Intervention: CON
Number of subjects: 42
Study 36107233 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study 35197344 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and nutrition programme for 12 months
Number of subjects: 15
Study 35197344 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control Group)
Number of subjects: 15
Study 32245513 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of xenon and dexmedetomidine
Number of subjects: 80
Study 32245513 — intervention group
Group type: COMPARATOR
Intervention: Mono-anesthesia with sevoflurane
Number of subjects: 80
Study 36082806 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-velocity concentric resistance training (FVCRT) for 10 weeks
Number of subjects: 30
Study 36082806 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 34491227 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO‐LLINs
Number of subjects: 0
Study 34491227 — intervention group
Group type: EXPERIMENTAL
Intervention: LLIN plus IRS with alternative‐insecticide
Number of subjects: 0
Study 34491227 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + IRS with alternative insecticide
Number of subjects: 0
Study 34491227 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + LLML
Number of subjects: 0
Study 34491227 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + IRS + LLML
Number of subjects: 0
Study 34491227 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO‐LLIN + LLML + IRS
Number of subjects: 0
Study 35872982 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 52
Study 35872982 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucagon levels
Number of subjects: 52